Coloplast A/S (CLPBY) Stock Forecast & Price Target

$6.19 +0.15 (+2.48%)

As of 07/24/2026 03:59 PM Eastern

Compare

Coloplast A/S - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Hold

Based on 3 Analyst Ratings

Sell
1

Hold
1

Buy
1

Based on 3 Wall Street analysts who have issued ratings for Coloplast A/S in the last 12 months, the stock has a consensus rating of "Hold." Out of the 3 analysts, 1 has given a sell rating, 1 has given a hold rating, and 1 has given a strong buy rating for CLPBY.

Consensus Price Target

N/A

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for CLPBY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Coloplast A/S and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLPBY Analyst Ratings Over Time

Type	Current Forecast 7/25/25 to 7/25/26	1 Month Ago 6/25/25 to 6/25/26	3 Months Ago 4/26/25 to 4/26/26	1 Year Ago 7/25/24 to 7/25/25
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	N/A	N/A	N/A	N/A
Forecasted Upside	N/A	N/A	N/A	N/A
Consensus Rating	Hold	Hold	Reduce	Hold

CLPBY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CLPBY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Coloplast A/S Stock vs. The Competition

Type	Coloplast A/S	Medical Companies	Broader Market
Consensus Rating Score	2.33	2.29	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	N/A	974.40% Upside	14.30% Upside
News Sentiment Rating	Negative News See Recent CLPBY News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating
5/20/2026	Kepler Capital Markets 2 of 5 stars		Upgrade	Strong-Buy
4/7/2026	The Goldman Sachs Group 3 of 5 stars		Downgrade	Hold ➝ Strong Sell
1/28/2026	Sanford C. Bernstein 3 of 5 stars		Upgrade	Hold
5/9/2025	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	J. Reynolds-Clar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Moderate Buy ➝ Hold
5/7/2025	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	H. Al-Wakeel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
12/11/2024	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Graham Doyle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
11/18/2024	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	S. Gupta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Moderate Sell ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:45 PM ET.

Should I Buy Coloplast A/S Stock? CLPBY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, July 23, 2026. Please send any questions or comments about these Coloplast A/S pros and cons to contact@marketbeat.com.

Coloplast A/S
Bull Case

Here are some ways that investors could benefit from investing in Coloplast A/S:

Coloplast A/S has a strong focus on innovative medical devices, particularly in intimate healthcare, which positions the company well in a growing market.
The current stock price is around $7.92, reflecting a recent gap down, which may present a buying opportunity for investors looking for value.
Analyst ratings have shown positive movement, with recent upgrades indicating growing confidence in the company's future performance.
Coloplast A/S specializes in long-term care solutions, such as ostomy and continence care products, which are essential for patients with chronic conditions, ensuring a steady demand.
The company is committed to improving quality of life through its products, which can lead to strong customer loyalty and repeat business.

Coloplast A/S
Bear Case

Investors should be bearish about investing in Coloplast A/S for these reasons:

The stock has experienced volatility, with a recent gap down in share price, which may indicate underlying issues or market concerns.
Despite a consensus rating of "Hold," there is no strong buy signal, suggesting that potential upside may be limited in the near term.
Coloplast A/S operates in a highly competitive market, which could impact its market share and pricing power.
Investors may be cautious due to the company's reliance on specific product lines, which could be vulnerable to changes in healthcare regulations or reimbursement policies.
Market sentiment can shift quickly, and any negative news or earnings reports could further affect the stock price negatively.

CLPBY Forecast - Frequently Asked Questions

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Coloplast A/S in the last twelve months. There is currently 1 sell rating, 1 hold rating and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CLPBY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLPBY, but not buy additional shares or sell existing shares.

According to analysts, Coloplast A/S's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Over the previous 90 days, Coloplast A/S's stock had 1 upgrade by analysts.

Coloplast A/S has been rated by research analysts at Kepler Capital Markets in the past 90 days.

Analysts like Coloplast A/S more than other "medical" companies. The consensus rating score for Coloplast A/S is 2.33 while the average consensus rating score for "medical" companies is 2.29. Learn more on how CLPBY compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Coloplast A/S Recommendations

This page (OTCMKTS:CLPBY) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Coloplast A/S (CLPBY) Stock Forecast & Price Target

Coloplast A/S - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CLPBY Analyst Ratings Over Time

CLPBY Analyst Recommendations By Month

CLPBY Price Targets by Month

Coloplast A/S Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Coloplast A/S Stock? CLPBY Pros and Cons Explained

Coloplast A/S
Bull Case

Coloplast A/S
Bear Case

CLPBY Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Coloplast A/S Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Coloplast A/S (CLPBY) Stock Forecast & Price Target

Coloplast A/S - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CLPBY Analyst Ratings Over Time

CLPBY Analyst Recommendations By Month

CLPBY Price Targets by Month

Coloplast A/S Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Coloplast A/S Stock? CLPBY Pros and Cons Explained

Coloplast A/S Bull Case

Coloplast A/S Bear Case

CLPBY Forecast - Frequently Asked Questions

Should I buy or sell Coloplast A/S stock right now?

Does Coloplast A/S's stock price have much downside?

Has Coloplast A/S been upgraded by Wall Street analysts recently?

What analysts cover Coloplast A/S?

Do Wall Street analysts like Coloplast A/S more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Coloplast A/S Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Coloplast A/S
Bull Case

Coloplast A/S
Bear Case